China Pharma Holdings, Inc.CPHINYSE
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank7
3Y CAGR-57.3%
5Y CAGR-29.1%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-57.3%/yr
vs +39.3%/yr prior
5Y CAGR
-29.1%/yr
Recent deceleration
Acceleration
-96.6pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
3 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 8.98 | -1.8% |
| 2023 | 9.15 | -70.6% |
| 2022 | 31.14 | -73.0% |
| 2021 | 115.44 | +22.0% |
| 2020 | 94.62 | +89.3% |
| 2019 | 50.00 | +3.8% |
| 2018 | 48.15 | +57.1% |
| 2017 | 30.65 | -20.4% |
| 2016 | 38.51 | +116.5% |
| 2015 | 17.79 | - |